ANDA 91345, held by Zydus Pharms. Desmopressin Acetate.
As of Nov 16, 2026, ANDA 91345 (Desmopressin Acetate (Needs No Refrigeration)), held by Zydus Pharms, was first approved by FDA on Oct 3, 2017, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 3, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desmopressin Acetate (Needs No Refrigeration)0.01MG/SPRAY · spray, metered;nasal | Desmopressin Acetate | Rx |
| Oct 25, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 3, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters